Compare TVRD & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVRD | USEG |
|---|---|---|
| Founded | 2017 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 34.3M |
| IPO Year | N/A | N/A |
| Metric | TVRD | USEG |
|---|---|---|
| Price | $4.37 | $1.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $51.67 | $3.50 |
| AVG Volume (30 Days) | 109.7K | ★ 1.8M |
| Earning Date | 02-21-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,484,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $57.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.74 | $0.91 |
| 52 Week High | $43.65 | $3.56 |
| Indicator | TVRD | USEG |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 50.62 |
| Support Level | $4.39 | $0.96 |
| Resistance Level | $4.89 | $1.06 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 43.63 | 33.81 |
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.